Constipation Clinical Trial
Official title:
The Efficacy of Individualised Homeopathic Treatment on Constipation
Constipation is an umbrella term encompassing either infrequent bowel movements, difficult
evacuation of stool, hard stool or a sensation of incomplete defecation. It affects 10-15%
of the global population. Constipation may negatively impact physical health, moods and
social life. There exists a 50% dissatisfaction with traditional approach of laxative use.
Conventional laxatives only offer a temporary solution and may cause dependency.
Side-effects of conventional laxatives include nausea, vomiting, flatulence, diarrhoea,
abdominal pain, electrolyte imbalance and skin eruptions. Homeopathy is a potential
treatment option for constipation, however further research is needed in this regard.
The aim of this study is to determine the efficacy of individualised homeopathic treatment
on constipation using case studies, an adapted Bowel Function Diary and the Bristol Stool
Form Scale.
The research study will be of an embedded mixed method case study design and take place over
a 6 week period at the University of Johannesburg Doornfontein Health Centre. Ten
participants of either gender, between the ages of 18 to 50 years will be recruited using
advertisements placed at the Doornfontein campus Health Centre.Those interested in
participating in the research will be requested to attend an initial meeting in which they
will receive a Participant Information Form and be requested to sign a Consent Form.
Participants meeting the inclusion criteria will be recruited into the study and a Selection
Questionnaire confirming their constipation status will be completed with the help of the
researcher. The researcher will then perform a full case taking and relevant physical
examination of the participant, the details of which will be recorded on a homeopathic Case
Taking Form, as designed by the researcher. The characteristic details of the case will then
be identified and analysed using using the Mercurius software Repertory. The homeopathic
Materia Medica will be referred to in order to confirm the remedy which best suits the
presenting symptomology of the participant. The repertorisation and remedy selection will be
conducted under the supervision of a qualified homeopath.
The potency, dose and frequency of the selected remedy will be determined according to the
laws that govern individualised homeopathic prescribing.
The remedy will be administered along with an explanation and demonstration on how to take
the remedy. A set of written instructions will be provided for the participant in the form
of a Patient Information Leaflet.
The participant will be requested to monitor each defecation session and a Bowel Function
Diary will be used to record the frequency of defecation, the stool form and the level of
difficulty on passing a stool. Participants will return for three follow up consultations at
2 week intervals. If dramatic changes occur in the participant, they will be requested to
contact the researcher, who will adjust the treatment accordingly.
At each follow up consultation, the participant's case will be re-evaluated with special
attention made to changes in symptoms or the appearance of new symptoms, the details of
which will be recorded on the Case Follow Up Form, as designed by the researcher. A remedy
will be prescribed in the same manner as the initial consultation. The prescription may be
repeated or altered in accordance with the participant's presenting symptoms and response to
the previous prescription. The laws that govern individualised homeopathic prescribing will
be used at all times in determining a prescription.
The qualitative data collected from the case taking forms, will be used by the researcher to
write detailed case studies. The quantitative data collected, using the Bowel Function Diary
and Bristol Stool Form Scale, will be used to assess the participants' changes in defecation
quality and frequency over the course of treatment, the results of which will be represented
graphically.
This study will contribute to the body of knowledge of the homeopathic treatment of
constipation and may provide a foundation for further research on the efficacy of
individualised homeopathic treatment of constipation.
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Recruiting |
NCT06292949 -
Clinical Study of Resistant Starch in Improving Constipation
|
N/A | |
Recruiting |
NCT04132661 -
MRI Assessment of Mode of Action of Bisacodyl, Single Dose
|
Phase 4 | |
Terminated |
NCT02839889 -
Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)
|
Phase 4 | |
Completed |
NCT02726295 -
The Efficacy of Mutaflor(E. Coli Nissle 1917, Mutaflor®) for Chronic Constipation:Multicenter Study
|
Phase 4 | |
Recruiting |
NCT02255747 -
Anal Dilatation for Infants and Children With Constipation
|
N/A | |
Completed |
NCT02246647 -
Biomarkers for Intestinal Permeability in Patients With Constipation
|
||
Completed |
NCT01566409 -
Maintenance Treatment for Children With Constipation
|
N/A | |
Completed |
NCT02863848 -
Effect of Inulin-type Fructans on Constipated Children.
|
N/A | |
Completed |
NCT02658201 -
Ultrafast MRI Imaging to Exclude Constipation
|
N/A | |
Completed |
NCT01695915 -
Diurnal Variation in Rectal Diameter
|
N/A | |
Completed |
NCT01710579 -
Normal Values in Ano-rectal 3D High Resolution Manometry
|
N/A | |
Completed |
NCT01438567 -
A Study to Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer Therapy
|
Phase 3 | |
Completed |
NCT01411501 -
Efficacy and Safety of Acupuncture for Functional Constipation
|
Phase 3 | |
Completed |
NCT01474499 -
A Trial of Docusate Sodium and Sorbitol Rectal Solution for the in Patients With Constipation
|
Phase 3 | |
Completed |
NCT00931853 -
Efficacy and Tolerability of Cassia Fistula Plus Senna Alexandrina Miller (Sugar Free) in the Chronic Functional Constipation (CFC).
|
Phase 3 | |
Completed |
NCT01170039 -
The Effectiveness of Lubiprostone in Constipated Diabetics
|
Phase 4 | |
Active, not recruiting |
NCT02442115 -
Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
|
||
Completed |
NCT00994851 -
Evaluation of Cassia Fistula + Senna Alexandrina Miller in the Chronic Functional Constipation Treatment.
|
Phase 3 | |
Terminated |
NCT01003249 -
Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen
|
Phase 4 |